US · KRO · CHEMICALS - SPECIALTY
Kronos Worldwide, Inc. (KRO) intrinsic value and stock valuation
$7.12as of 2026-11-21 · Mkt cap 714.48M
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Kronos Worldwide, Inc. DCF and intrinsic value
InvestorsCraft values KRO with the Chepakovich two-stage DCF model — currently rated undervalued. How the model works · Run your own DCF prefilled from KRO’s statements →
Kronos Worldwide, Inc. Graham Number
The Graham Number is not defined for negative earnings or book value. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.86B | $1.89B | $1.67B | $1.93B | $1.94B |
| Operating income | -$-41.9M | $122.9M | -$-56M | $159.6M | $187.1M |
| Net income | -$-110.9M | $86.2M | -$-49.1M | $104.5M | $112.9M |
| EPSd | -$-964.35K | $749.6K | -$-426.59K | $904.8K | $977.5K |
| Operating cash flow | $2.5M | $72.5M | $5.5M | $81.7M | $206.5M |
| Capital expenditure | -$-42.9M | -$-29.5M | -$-47.4M | -$-63.2M | -$-58.6M |
| Free cash flow | -$-40.4M | $43M | -$-41.9M | $18.5M | $147.9M |
| Total assets | $1.82B | $1.91B | $1.84B | $1.93B | $2.01B |
| Total debt | $577.3M | $528M | $463.4M | $446.4M | $470.7M |
| Net debt | $540.3M | $421.3M | $268.7M | $118.6M | $64.7M |
| Total equity | $751.1M | $817M | $808.3M | $957.2M | $870.2M |
| Cash and short-term investments | $37M | $106.7M | $194.7M | $327.8M | $406M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $1.86B | $1.89B | $1.67B | $1.93B | $1.94B |
| Cost of revenue | $1.65B | $1.53B | $1.5B | $1.54B | $1.49B |
| Gross profit | $213M | $359.3M | $164.9M | $391.1M | $446.2M |
| Research and development expenses | $16M | $14M | $18M | $0.00 | $0.00 |
| Selling, general and administrative expenses | $229.2M | $211.6M | $211.2M | $231.3M | $248.9M |
| Other expenses | $9.7M | $10.8M | -$-8.3M | $200K | $10.2M |
| Operating expenses | $254.9M | $236.4M | $220.9M | $231.5M | $259.1M |
| Cost and expenses | $1.9B | $1.76B | $1.72B | $1.77B | $1.75B |
| Interest income | $1.2M | $5.5M | $6.9M | $5.1M | $400K |
| Interest expense | $53M | $42.9M | $17.1M | $16.9M | $19.6M |
| Depreciation and amortization | $64.8M | $64.4M | $53.1M | $56.2M | $57.9M |
| Ebitda | $20.4M | $256.9M | -$-2.7M | $207M | $230.9M |
| Operating income | -$-41.9M | $122.9M | -$-56M | $159.6M | $187.1M |
| Total other income/expenses, net | -$-55.5M | $26.7M | -$-16.9M | -$-25.7M | -$-33.7M |
| Income before tax | -$-97.4M | $149.6M | -$-72.9M | $133.9M | $153.4M |
| Income tax expense | $13.5M | $63.4M | -$-23.8M | $29.4M | $40.5M |
| Net income | -$-110.9M | $86.2M | -$-49.1M | $104.5M | $112.9M |
| Weighted average shares outstanding | $115M | $115M | $115.1M | $115.5M | $115.5M |
| Weighted average diluted shares outstanding | $115M | $115M | $115.1M | $115.5M | $115.5M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $37M | $106.7M | $194.7M | $327.8M | $406M |
| Net receivables | $287.8M | $291.6M | $312.5M | $255.1M | $379.1M |
| Inventory | $628.6M | $656.7M | $564.6M | $608.7M | $432.3M |
| Total current assets | $994.5M | $1.11B | $1.12B | $1.24B | $1.26B |
| Property, plant and equipment, net | $744.2M | $714.7M | $505.6M | $506M | $523.3M |
| Goodwill and intangible assets | $2.6M | $2.6M | $0.00 | $0.00 | $0.00 |
| Long-term investments | $7.3M | $3.4M | $113.2M | $116.1M | $106.1M |
| Total non-current assets | $822.3M | $808.2M | $720.6M | $692.2M | $754.8M |
| Total assets | $1.82B | $1.91B | $1.84B | $1.93B | $2.01B |
| Accounts payable | $224M | $232.4M | $218.7M | $177.2M | $143.6M |
| Short-term debt | $4.2M | $81.8M | $7.8M | $4.9M | $5.1M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $368.8M | $476.6M | $370.8M | $326.7M | $288.8M |
| Long-term debt | $573.1M | $446.2M | $459.5M | $441.5M | $465.6M |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $696.9M | $619.9M | $658.9M | $650.5M | $853.8M |
| Capital lease obligations | $19.9M | $20.6M | $22.5M | $21.2M | $19.5M |
| Total liabilities | $1.07B | $1.1B | $1.03B | $977.2M | $1.14B |
| Common stock | $1.2M | $1.2M | $1.2M | $1.2M | $1.2M |
| Retained earnings | -$-344.9M | -$-211M | -$-242M | -$-105.4M | -$-122.1M |
| Accumulated other comprehensive income (loss) | -$-295.6M | -$-363.5M | -$-341.1M | -$-331.5M | -$-404.1M |
| Total equity | $751.1M | $817M | $808.3M | $957.2M | $870.2M |
| Total investments | $7.3M | $3.4M | $113.2M | $116.1M | $106.1M |
| Total debt | $577.3M | $528M | $463.4M | $446.4M | $470.7M |
| Net debt | $540.3M | $421.3M | $268.7M | $118.6M | $64.7M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | -$-110.9M | $86.2M | -$-49.1M | $104.5M | $112.9M |
| Depreciation and amortization | $64.8M | $64.4M | $53.1M | $56.2M | $57.9M |
| Stock-based compensation | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | $47.1M | -$-42.3M | $36.2M | -$-80.3M | $6.9M |
| Accounts receivable | $31.7M | -$-8.4M | -$-43.9M | $85.7M | -$-58.6M |
| Inventory | $77M | -$-43.1M | $56.3M | -$-198.4M | $65.8M |
| Accounts payable | -$-25.6M | $11.6M | $33.9M | $36.7M | $0.00 |
| Net cash provided by operating activities | $2.5M | $72.5M | $5.5M | $81.7M | $206.5M |
| Investments in property, plant and equipment | -$-42.9M | -$-29.5M | -$-47.4M | -$-63.2M | -$-58.6M |
| Acquisitions, net | $0.00 | -$-156.8M | $0.00 | $0.00 | $0.00 |
| Net cash used for investing activities | -$-42.9M | -$-186.3M | -$-47.4M | -$-63.1M | -$-58.6M |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | $0.00 | $0.00 | -$-2.9M | -$-2.3M | -$-200K |
| Dividends paid | -$-23M | -$-55.2M | -$-87.5M | -$-87.8M | -$-83.2M |
| Net cash used for financing activities | -$-36.3M | $26.5M | -$-91.6M | -$-91.5M | -$-86.7M |
| Net change in cash | -$-73M | -$-87.4M | -$-132.5M | -$-78M | $50.6M |
| Cash at end of period | $37M | $114.7M | $202.1M | $334.6M | $412.6M |
| Operating cash flow | $2.5M | $72.5M | $5.5M | $81.7M | $206.5M |
| Capital expenditure | -$-42.9M | -$-29.5M | -$-47.4M | -$-63.2M | -$-58.6M |
| Free cash flow | -$-40.4M | $43M | -$-41.9M | $18.5M | $147.9M |
Line items
Line items
Line items
About Kronos Worldwide, Inc.
Kronos Worldwide, Inc. stands as a prominent global producer and supplier of titanium dioxide (TiO2) pigments, with operations spanning Europe, North America, the Asia Pacific, and other international territories. The company manufactures TiO2 in both its rutile and anatase crystalline structures, which are essential for contributing whiteness, brilliance, opacity, and resilience to a broad spectrum of goods. This includes everyday items such as paints, coatings, plastics, paper, fibers, and ceramics, alongside specialized applications in inks, food products, and cosmetics. In addition to its primary TiO2 business, Kronos also processes ilmenite, a foundational raw material crucial for sulfate-process TiO2 manufacturing facilities. Its diverse product portfolio further encompasses iron-based chemicals, which are indispensable for treating and conditioning industrial and municipal wastewater, as well as for use in producing iron pigments, cement, and various agricultural solutions. The firm also develops specialized chemicals utilized in crafting pearlescent pigments, fabricating electroceramic capacitors for mobile phones and other electronic gadgets, and for various specific industrial purposes, including natural gas piping. The company extends technical support and services for its entire product range. Its KRONOS-branded offerings are distributed to manufacturers of paints, plastics, decorative laminates, and paper via an extensive network of agents and distributors. Founded in 1916, Kronos Worldwide, Inc. maintains its corporate headquarters in Dallas, Texas, and operates as a subsidiary of Valhi, Inc.
- CEO
- Brian W. Christian
- Employees
- 2.26K
- Beta
- 0.98
Explore
Frequently asked questions
What is the intrinsic value of Kronos Worldwide, Inc. (KRO)?
Kronos Worldwide, Inc. (KRO) is currently undervalued based on the InvestorsCraft IC model — IC value is 20–50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is KRO undervalued?
KRO trades at a price of $7.12 (Nov 21, 2026): undervalued — IC value is 20–50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.